The effects of lidocaine on nitric oxide production from an activated murine macrophage cell line
- PMID: 11133614
- DOI: 10.1097/00000539-200101000-00025
The effects of lidocaine on nitric oxide production from an activated murine macrophage cell line
Abstract
Nitric oxide (NO), overproduced by activated macrophages, is important in the pathogenesis of various diseases, including septic shock and inflammatory tissue injury, as well as antibacterial host defense mechanisms. We examined the effects of lidocaine on NO production and the expression of inducible NO synthase (iNOS) protein and messenger RNA (mRNA) in activated macrophages. Murine macrophage-like cell line RAW 264 was stimulated for 8 h with lipopolysaccharide (10 mg/mL) and interferon-gamma (50 U/mL) in the presence of various concentrations of lidocaine (0-500 mg/mL). NO production was assessed by measuring levels of the stable metabolites, nitrite and nitrate (NOx), in the culture medium with an automatic analyzer using the Griess reaction. Expression of iNOS mRNA in harvested RAW 264 was quantified by Northern blot analysis using mouse iNOS complementary DNA probe. Expression of iNOS protein in the cells was assessed by Western blot analysis using anti-iNOS antibody. Lidocaine dose-dependently attenuated the increase in NOx levels in response to the stimulants. The drug at any concentration failed to decrease iNOS mRNA expression in RAW 264. Lidocaine at 500 mg/mL decreased iNOS protein levels. These data suggest that lidocaine reduced NO production in activated macrophages at multiple levels after transcription. The inhibitory site appeared to vary with the dose of lidocaine.
Implications: Lidocaine dose-dependently inhibited nitric oxide production by activated macrophages, presumably at levels after transcription. The attenuating effect of lidocaine on organ injuries previously reported may be explained by the ability of the drug to suppress this inflammatory mediator.
Similar articles
-
Anesthetic modulation of immune reactions mediated by nitric oxide.J Anesth. 2008;22(2):155-62. doi: 10.1007/s00540-007-0590-2. Epub 2008 May 25. J Anesth. 2008. PMID: 18500613 Review.
-
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.J Immunol. 1999 Apr 15;162(8):4685-96. J Immunol. 1999. PMID: 10202009
-
Volatile anesthetics differentially affect immunostimulated expression of inducible nitric oxide synthase: role of intracellular calcium.Anesthesiology. 2000 Apr;92(4):1093-102. doi: 10.1097/00000542-200004000-00028. Anesthesiology. 2000. PMID: 10754630
-
Inhibitory effects of phloroglucinol derivatives from Mallotus japonicus on nitric oxide production by a murine macrophage-like cell line, RAW 264.7, activated by lipopolysaccharide and interferon-gamma.Biochim Biophys Acta. 2001 Nov 7;1568(1):74-82. doi: 10.1016/s0304-4165(01)00203-3. Biochim Biophys Acta. 2001. PMID: 11731088
-
Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7: Version 2.2020 Sep. In: National Cancer Institute’s Nanotechnology Characterization Laboratory Assay Cascade Protocols [Internet]. Bethesda (MD): National Cancer Institute (US); 2005 May 1–. NCL Method ITA-7. 2020 Sep. In: National Cancer Institute’s Nanotechnology Characterization Laboratory Assay Cascade Protocols [Internet]. Bethesda (MD): National Cancer Institute (US); 2005 May 1–. NCL Method ITA-7. PMID: 39013045 Free Books & Documents. Review.
Cited by
-
The 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its Use.Pain Ther. 2016 Dec;5(2):149-169. doi: 10.1007/s40122-016-0060-3. Epub 2016 Nov 7. Pain Ther. 2016. PMID: 27822619 Free PMC article. Review.
-
Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician.Clin Pharmacol. 2010;2:65-70. doi: 10.2147/CPAA.S9795. Epub 2010 Mar 30. Clin Pharmacol. 2010. PMID: 22291487 Free PMC article.
-
Viability and intracellular nitric oxide generation in the umbilical cord blood CD34+CD133- and CD34+CD133+ cell populations exposed to local anaesthetics.Cent Eur J Immunol. 2020;45(4):369-376. doi: 10.5114/ceji.2020.103410. Epub 2021 Jan 30. Cent Eur J Immunol. 2020. PMID: 33658886 Free PMC article.
-
A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis.Mol Pain. 2008 Oct 25;4:47. doi: 10.1186/1744-8069-4-47. Mol Pain. 2008. PMID: 18950528 Free PMC article.
-
Anesthetic modulation of immune reactions mediated by nitric oxide.J Anesth. 2008;22(2):155-62. doi: 10.1007/s00540-007-0590-2. Epub 2008 May 25. J Anesth. 2008. PMID: 18500613 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials